HIV HAART AIDS SIDA VIH HIV
insulin resistance C-Reactive protein (CRP)
  Español (soon!) - November 20, 2008
CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
 Conference
"Mise en route d’une thérapie HAART comprenant l’abacavir"
Dr. Richard Lalonde (biography)
French - 2007-03-15 - 25 minutes
(33 slides)

 Learning objectives :
 Au terme de ce module, le participant pourra :
- décrire les stratégies d’instauration d’une thérapie HAART
- expliquer les bienfaits du traitement par l’abacavir, tant initiaux que secondaires
- reconnaître les signes d’une réaction d’hypersensibilité à l’abacavir
- expliquer l’intérêt du typage HLA comme stratégie visant à réduire le risque de réactions d’hypersensibilité
   


  Login

  Please log in and get access to thousands of resources about HIV disease and its treatment.
 
Already a member?
  Username :
  Password :
   
 
  Lost your password?

  Search our database
  Find the information that you are looking for in over +3000 resources.
 
web cmeonhiv.com



ezCME: HIV - Insulin Resistance - C-Reactive Protein (CRP) - ADHD - Sleep Disorder - Prostate Health - Hemophilia - Transplantation

CMEonHIV is owned by E-MedHosting.com.

Copyright @ 2002-2008 E-MedHosting.com. All rights reserved.  Disclaimer  |  Sponsor Disclaimer
Powered by Multiwebcast - webcast services

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR
BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.